Cargando…
Transplacental Therapeutic Drug Monitoring in Pregnant Women with Fetal Tachyarrhythmia Using HPLC-MS/MS
Fetal arrhythmia develops in 0.1–5% of pregnancies and may cause fetal heart failure and fetal hydrops, thus increasing fetal, neonatal, and infant mortality. The timely initiation of transplacental antiarrhythmic therapy (ART) promotes the conversion of fetal tachycardia to sinus rhythm and the reg...
Autores principales: | Starodubtseva, Natalia, Kindysheva, Svetlana, Potapova, Alyona, Kukaev, Evgenii, Khodzhaeva, Zulfiya, Bockeria, Ekaterina, Chagovets, Vitaliy, Frankevich, Vladimir, Sukhikh, Gennady |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916042/ https://www.ncbi.nlm.nih.gov/pubmed/36768172 http://dx.doi.org/10.3390/ijms24031848 |
Ejemplares similares
-
Non-Invasive Differential Diagnosis of Cervical Neoplastic Lesions by the Lipid Profile Analysis of Cervical Scrapings
por: Tokareva, Alisa, et al.
Publicado: (2022) -
Validation of Breast Cancer Margins by Tissue Spray Mass Spectrometry
por: Chagovets, Vitaliy V., et al.
Publicado: (2020) -
COVID-19 Infection during Pregnancy: Disruptions in Lipid Metabolism and Implications for Newborn Health
por: Frankevich, Natalia, et al.
Publicado: (2023) -
Outcomes of sustained fetal tachyarrhythmias after transplacental treatment
por: Bartin, Raphael, et al.
Publicado: (2021) -
Shotgun Lipidomics for Differential Diagnosis of HPV-Associated Cervix Transformation
por: Starodubtseva, Natalia L., et al.
Publicado: (2022)